How should I manage a 72‑year‑old man on chronic warfarin who sustained a wrist injury after a ground‑level fall, with no head injury, loss of consciousness, nausea, vomiting, or amnesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 72-Year-Old Male on Warfarin with Wrist Injury After Ground-Level Fall

Obtain an immediate non-contrast head CT scan despite the absence of head injury symptoms, check INR and hemoglobin, and manage the wrist injury orthopedically without warfarin reversal unless active bleeding or urgent surgery is required. 1

Immediate Head Imaging is Mandatory

  • Obtain a non-contrast head CT scan immediately, even though the patient denies head injury, loss of consciousness, nausea, vomiting, or amnesia. 2
  • Warfarin increases the odds of intracranial hemorrhage by 40% after head trauma and doubles the risk of mortality in elderly patients. 1
  • The risk of intracranial hemorrhage in anticoagulated patients after trauma is 10.2% compared to 1.5% in non-anticoagulated patients. 3
  • Ground-level falls are the most common mechanism of traumatic intracranial hemorrhage in elderly patients on warfarin, with mortality rates reaching 50% when hemorrhage occurs. 4
  • Age >65 years combined with warfarin and any head trauma creates a lethal triad that frequently produces fatal brain hemorrhage. 4

Laboratory Assessment

  • Check INR, complete blood count with hemoglobin, platelet count, and creatinine immediately. 1
  • Document the degree of coagulopathy on presentation, as bleeding risk increases with higher INR values. 1
  • Obtain baseline labs to guide potential reversal decisions if hemorrhage is discovered. 1

Wrist Injury Management Without Reversal

Do NOT reverse warfarin for an isolated wrist injury unless there is major life-threatening bleeding, bleeding not responding to supportive measures, or urgent surgical intervention is required. 1

Criteria for Warfarin Reversal (None Apply to This Case):

  • Major life-threatening bleeding 1
  • Bleeding located in critical organs (central nervous system, abdominal, thoracic) 1
  • Bleeding not responding to supportive measures 1
  • Urgent surgical or invasive procedures requiring hemostasis 1

If Reversal Were Needed:

  • Administer 4-factor prothrombin complex concentrate (4F-PCC) plus 5 mg intravenous vitamin K to achieve INR <1.5. 1
  • Fresh frozen plasma should only be used if no other reversal agent is available. 1
  • Do not use recombinant activated factor VII (rFVIIa) as first-line reversal. 1

Management Based on Head CT Results

If Head CT is Negative:

  • Discharge the patient home with clear written instructions about signs of delayed hemorrhage (severe headache, confusion, vomiting, weakness, seizures, worsening drowsiness, slurred speech, vision changes). 3, 2
  • Continue warfarin without interruption if the patient is neurologically intact with negative CT, as the risk of delayed intracranial hemorrhage requiring intervention is <1%. 2
  • Arrange close observation by a responsible adult for the next 24 hours who can monitor continuously for warning signs. 3
  • Do NOT perform routine repeat head CT in neurologically intact patients with negative initial CT, as the risk of deterioration is extremely low (0.006%). 2
  • The risk of delayed intracranial hemorrhage is 0.6-6% for warfarin patients with negative initial CT, but rarely requires neurosurgical intervention. 3, 2

If Head CT Shows Intracranial Hemorrhage:

  • Immediately administer 4F-PCC plus 5 mg intravenous vitamin K to achieve INR <1.5. 1
  • Obtain immediate neurosurgical consultation. 3, 2
  • Obtain repeat head CT within 24 hours, as anticoagulated patients have a 3-fold increased risk of hemorrhage expansion (26% versus 9%). 3, 2
  • Perform immediate repeat CT for any neurological deterioration regardless of time since injury. 2
  • Hold warfarin until cleared by neurosurgery. 3

Wrist Fracture Management

  • Proceed with standard orthopedic evaluation and treatment (radiographs, splinting, orthopedic referral). 1
  • If closed reduction or surgical fixation is required, assess the bleeding risk of the procedure. 1
  • For low-bleeding risk procedures (closed reduction, splinting), warfarin can typically be continued. 1
  • For high-bleeding risk procedures (open reduction internal fixation), warfarin should be stopped 5-6 days before surgery to allow INR to normalize, with bridging anticoagulation considered based on thromboembolic risk. 1

Trauma Activation Considerations

  • Use lower threshold for trauma activation in geriatric patients: heart rate >90 bpm and systolic blood pressure <110 mmHg. 1
  • Elderly patients on warfarin have blunted physiologic responses to injury due to medications like beta-blockers and age-related cardiovascular changes. 1
  • Document the patient's polypharmacy profile, including beta-blockers, steroids, and other anticoagulants/antiplatelets. 1

Common Pitfalls to Avoid

  • Do not skip head CT imaging based on absence of symptoms—warfarin dramatically increases occult hemorrhage risk even with minor mechanisms. 2, 4
  • Do not routinely reverse warfarin for non-critical bleeding or minor procedures, as this increases thromboembolic risk without clear benefit. 1
  • Do not perform unnecessary repeat imaging in stable patients with negative initial CT and normal neurological exam. 2
  • Do not discontinue warfarin unnecessarily without considering the indication and thromboembolic risk. 3, 2
  • Do not use fresh frozen plasma as first-line reversal when PCC is available, as FFP requires longer infusion time, ABO compatibility testing, and carries higher risk of volume overload and transfusion reactions. 1

Outpatient Follow-Up

  • Arrange fall risk assessment to prevent future injuries. 3, 2
  • Reassess the risk/benefit ratio of continued anticoagulation given fall risk. 3, 2
  • Consider lower therapeutic INR targets (1.6-2.5) in frail elderly patients to reduce bleeding risk while maintaining approximately 80% of anticoagulation efficacy. 5
  • Schedule INR monitoring within 1 week if warfarin dosing was adjusted. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Imaging Guidelines for Patients on Apixaban Anticoagulation with Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Head Injury in Patients on Anticoagulants and Chemotherapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Warfarin Therapy in Frail Elderly Patients with Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How should an elderly patient on chronic warfarin who sustained a ground‑level fall without obvious head injury be managed?
In an elderly patient on warfarin who sustains a ground‑level fall without obvious head injury, should an emergent non‑contrast head CT be obtained?
In an elderly patient on warfarin who sustained a ground‑level fall without obvious head injury and has a normal Glasgow Coma Scale, should an emergent non‑contrast head CT be performed?
What is the management approach for an elderly patient on anticoagulant (anticoagulant) therapy who has fallen?
According to the CEP guidelines, does an elderly patient (≥65) on warfarin who sustains a ground‑level fall without obvious head injury require an immediate non‑contrast head CT?
Why does cortical venous thrombosis occur during pregnancy?
What are the recommended dosing, contraindications, dose adjustments, and common adverse effects of desvenlafaxine (serotonin‑norepinephrine reuptake inhibitor) for treating major depressive disorder in adults?
What is the best way to differentiate renal amyloidosis from multiple myeloma–related light‑chain cast nephropathy (myeloma kidney)?
What are the possible etiologies and initial work‑up for dizziness in a 52‑year‑old adult?
What is the safest way to titrate bumetanide (Bumex) to 1 mg twice daily in a 71‑year‑old woman with chronic heart failure and chronic respiratory failure?
Patient with known hypercalcemia has serum calcium 11.7 mg/dL and intact parathyroid hormone 84 pg/mL—how should I explain these findings in simple terms to a new nurse practitioner?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.